Equibles does not estimate personal net worth.
Get an email with a short summary when Boston Scientific Corp publishes a filing, an earnings call transcript or a press release.
Get BSX alertsJoseph M. Fitzgerald is recorded as Board Member at Chain Bridge Bancorp Inc (CBNA). The newest filing on record that lists Joseph M. Fitzgerald as Board Member at Chain Bridge Bancorp Inc (CBNA) is dated April 28, 2026. The proxy statement of Boston Scientific Corp reports total compensation of $8,042,997 for Joseph M. Fitzgerald in fiscal 2025, including a base salary of $892,604. Disclosed compensation is on record for 9 fiscal years. Joseph M. Fitzgerald has spoken on 1 earnings call across 1 company, most recently for Boston Scientific Corp on October 28, 2026. Boston Scientific Corp is classified in the Medical Devices industry within the Healthcare sector. Chain Bridge Bancorp Inc is classified in the Banks - Regional industry within the Financial Services sector. Other leadership on record at Boston Scientific Corp includes Michael Mahoney (CEO), Jonathan Monson (CFO), Joe Fitzgerald (COO) and 7 others.
“As you know, Ultra is a PMA supplement, does not require a clinical study. So most of the issues we have there are just on getting through what we call design verification and validation.”
Proxy statement
Start not stated–present
Last confirmed March 24, 2021
Start not stated–present
Last confirmed April 28, 2026
Medical Devices · Healthcare
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Boston Scientific Corp (BSX) | Executive Vice President and Group President, Cardiovascular | $892,604 | $8,042,997 |
| 2024 | Boston Scientific Corp (BSX) | Executive Vice President and Group President, Cardiology | $842,360 | $6,335,804 |
| 2023 | Boston Scientific Corp (BSX) | Executive Vice President and Group President, Cardiology | $793,560 | $5,592,519 |
| 2022 | Boston Scientific Corp (BSX) | Executive Vice President and Group President, Cardiology | $740,178 | $4,764,586 |
| 2021 | Boston Scientific Corp (BSX) | Executive Vice President and Group President, Cardiology | $699,130 | $4,309,535 |
| 2020 | Boston Scientific Corp (BSX) | Executive Vice President and Group President, Cardiology | $568,679 | $4,598,333 |
| 2019 | Boston Scientific Corp (BSX) | Executive Vice President and President, Interventional Cardiology | $667,416 | $4,025,457 |
| 2018 | Boston Scientific Corp (BSX) | Executive Vice President and President, Interventional Cardiology | $639,958 | $4,036,318 |
| 2017 | Boston Scientific Corp (BSX) | Executive Vice President and President, Rhythm Management | $564,740 | $5,838,997 |
